NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD ...

The pharmaceutical industry is preparing for ‘major disruptions’ following US President Donald Trump’s announcement on ...

An Indian pharmaceutical company is manufacturing unlicensed, highly addictive opioids and exporting them illegally to West ...

The company is dedicated to maintaining the highest quality and regulatory standards while supporting smooth global business ...

While recruitment and regulation are improving, they remain pain points, say speakers at Arena International’s OCT West Coast ...

While Health Technology Assessment agencies anticipate that joint efforts and harmonisation will enhance evaluations’ ...

Q4 2024 Earnings Call Transcript February 19, 2025 BioMarin Pharmaceutical Inc. beats earnings expectations. Reported EPS is $0.64, expectations were $0.54. Operator: Ladies and gentlemen, thank you ...

DIA's Europe Annual Meeting, featuring discussions from top European health leaders, will be held March 18-20 in Basel.

South Korea-based Celltrion today announced that the European Commission (EC) has granted marketing authorization for three ...

The global Cystic Fibrosis Market is valued at $10.4 billion in 2023 and is projected to reach $55.4 billion by 2032, ...

Aiming to address the challenges of consumer demand for sustainable solutions and stricter regulations requiring greater ...